Skip to content

Stock-Based Comp at other companies

Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
$257.4M+0.7%
Opko Health logo
Opko HealthOPK
$2.74M+4.5%
Relay Therapeutics, Inc. logo
Relay Therapeutics, Inc.RLAY
$10.54M-45.5%
Zevra Therapeutics, Inc. logo
Zevra Therapeutics, Inc.ZVRA
$3.11M-0.3%
ALN
Alnylam PharmaceuticalsALNY
$70.15M+23.7%
Intellia Therapeutics logo
Intellia TherapeuticsNTLA
$13.48M-38.3%

Other financials

Income statement

See full
Revenue$293.0K-84.8%
Operating income-$40.8M+1.9%
Net income-$46.3M-15.8%
EPS (diluted)-$0.57-11.8%

Balance sheet

See full
Cash & equivalents$71.5M+7.5%
Total debt$62.7M-22.5%
Total equity-$58.1M-276%
Total assets$244.7M+9.2%

Cash flow

See full
Operating cash flow$17.8M+148%
CapEx$2.0M+17.4%
Free cash flow$15.8M+141%

Valuation

See full
Market cap$1.07B+111%
Enterprise value$1.07B+103%
P/S13.5×-1.3×

Profitability

See full
Operating margin-597.9%-207pp
Net margin-615.3%
FCF margin-441.5%-126pp

Returns & leverage

See full
Return on equity-379.5%
Debt / equity27.2×+26.1×
Current ratio0.5×-1.0×

Where this comes from

Reported directly by MeiraGTx Holdings plc in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensation.

The official record: MeiraGTx Holdings plc’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about MeiraGTx Holdings plc's stock-based comp.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is MeiraGTx Holdings plc's stock-based comp?
MeiraGTx Holdings plc (MGTX) reported stock-based comp of $3.65M in Q1 2026.
How has MeiraGTx Holdings plc's stock-based comp changed year-over-year?
MeiraGTx Holdings plc's stock-based comp decreased by 25.2% year-over-year, from $4.89M to $3.65M.
What is the long-term trend for MeiraGTx Holdings plc's stock-based comp?
Over 4 years (2021 to 2025), MeiraGTx Holdings plc's stock-based comp has grown at a 1.5% compound annual growth rate (CAGR), from $20.78M to $22.1M.
What does stock-based comp mean?
Total non-cash stock-based compensation expense for equity awards (RSUs, options, ESPP), added back to net income in cash flow reconciliation.